Clinical trialNCT00551369CompletedPhase 2Interventional

Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery

SponsorRadiation Therapy Oncology GroupEnrollment33Lung Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RATIONALE: Stereotactic body radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue near the tumor. PURPOSE: This phase II trial is studying how well stereotactic body radiation therapy works in treating patients with stage I or stage II non-small cell lung cancer that can be removed by surgery.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Elizabeth M. Gore, MD
Medical College of Wisconsin
Study Chair
clinicaltrials.gov ↗
Harvey I. Pass, MD
NYU Langone Health
Study Chair
clinicaltrials.gov ↗
Martin J. Edelman, MD
University of Maryland Greenebaum Cancer Center
Study ChairKOL profile →
clinicaltrials.gov ↗
Robert D. Timmerman, MD
Simmons Cancer Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Uab Comprehensive Cancer Center
Birmingham, Alabama, United States
Alta Bates Summit Comprehensive Cancer Center
Berkeley, California, United States
Mercy Cancer Center at Mercy San Juan Medical Center
Carmichael, California, United States
Marin Cancer Institute at Marin General Hospital
Greenbrae, California, United States
University of California Davis Cancer Center
Sacramento, California, United States
Memorial Hospital of South Bend
South Bend, Indiana, United States
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky, United States
Greenebaum Cancer Center at University of Maryland Medical Center
Baltimore, Maryland, United States
Lacks Cancer Center at Saint Mary'S Health Care
Grand Rapids, Michigan, United States
William Beaumont Hospital - Royal Oak Campus
Royal Oak, Michigan, United States
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
St Louis, Missouri, United States
Nyu Cancer Institute at New York University Medical Center
New York, New York, United States
Stony Brook University Cancer Center
Stony Brook, New York, United States
Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
Penn State Cancer Institute at Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
Dallas, Texas, United States
Inova Alexandria Hospital
Alexandria, Virginia, United States
St. Joseph Cancer Center
Bellingham, Washington, United States
Medical College of Wisconsin Cancer Center
Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Dec 2007
Primary completion: 31 May 2012
Completion: 14 May 2018
Last update posted: 30 Apr 2019
Registered enrollment: 33
Registry id: NCT00551369

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.